Pfizer receives all required regulatory approvals to complete the acquisition of seagen

New york--(business wire)--pfizer inc. (nyse: pfe) today announces that the waiting period under the hart-scott-rodino antitrust improvements act of 1976, as amended, expired december 11, 2023, with respect to pfizer's pending acquisition of seagen inc. (nasdaq: sgen). pfizer and seagen have now received all required regulatory approvals to complete the acquisition. pfizer expects to close the acquisition of seagen on december 14, 2023, subject to the satisfaction of other customary closing con.
SGEN Ratings Summary
SGEN Quant Ranking